Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 325

1.

A novel transcatheter aortic valve with a form-fitting anchor for self-alignment: feasibility in a chronic preclinical model.

Noterdaeme T, Marx N, Lange R.

Interact Cardiovasc Thorac Surg. 2019 Feb 14. pii: ivz005. doi: 10.1093/icvts/ivz005. [Epub ahead of print]

PMID:
30768173
2.

FDA Guidance on Antihyperglycemic Therapies for Type 2 Diabetes: One Decade Later.

McGuire DK, Marx N, Johansen OE, Inzucchi SE, Rosenstock J, George JT.

Diabetes Obes Metab. 2019 Jan 28. doi: 10.1111/dom.13645. [Epub ahead of print]

PMID:
30690856
3.

Cardiovascular Benefits of GLP-1 Receptor Agonism: Is Inflammation a Key?

Marx N, Libby P.

JACC Basic Transl Sci. 2018 Dec 31;3(6):858-860. doi: 10.1016/j.jacbts.2018.11.008. eCollection 2018 Dec. No abstract available.

4.

Oral Anticoagulation.

Altiok E, Marx N.

Dtsch Arztebl Int. 2018 Nov 16;115(46):776-783. doi: 10.3238/arztebl.2018.0776.

5.

Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials.

Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Ukena C, Mann JFE, Mancia G, Redon J, Schmieder RE, Sliwa K, Marx N, Weber MA, Williams B, Yusuf S.

Eur Heart J. 2018 Dec 24. doi: 10.1093/eurheartj/ehy808. [Epub ahead of print]

PMID:
30590564
6.

Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA.

McGuire DK, Alexander JH, Johansen OE, Perkovic V, Rosenstock J, Cooper ME, Wanner C, Kahn SE, Toto RD, Zinman B, Baanstra D, Pfarr E, Schnaidt S, Meinicke T, George JT, von Eynatten M, Marx N; CARMELINA Investigators.

Circulation. 2019 Jan 15;139(3):351-361. doi: 10.1161/CIRCULATIONAHA.118.038352.

PMID:
30586723
7.

AnnexinA5-pHrodo: a new molecular probe for measuring efferocytosis.

Stöhr R, Deckers N, Schurgers L, Marx N, Reutelingsperger CP.

Sci Rep. 2018 Dec 7;8(1):17731. doi: 10.1038/s41598-018-35995-z.

8.

Development of the Metabolic Syndrome: Study Design and Baseline Data of the Lufthansa Prevention Study (LUPS), A Prospective Observational Cohort Survey.

Müller-Wieland D, Altenburg C, Becher H, Burchard J, Frisch A, Gebhard J, Haas J, Harth V, Heeren J, Hengelbrock J, von Karais M, Knebel B, Kotzka J, Löwe B, Marx N, Pinnschmidt H, Preisser A, Rose M, Sawitzky-Rose B, Scheja L, Terschüren C, Töller M, Vettorazzi E, Wegscheider K.

Exp Clin Endocrinol Diabetes. 2018 Nov 26. doi: 10.1055/a-0767-6361. [Epub ahead of print]

PMID:
30477037
9.

Empagliflozin Increases Cardiac Energy Production in Diabetes: Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors.

Verma S, Rawat S, Ho KL, Wagg CS, Zhang L, Teoh H, Dyck JE, Uddin GM, Oudit GY, Mayoux E, Lehrke M, Marx N, Lopaschuk GD.

JACC Basic Transl Sci. 2018 Aug 26;3(5):575-587. doi: 10.1016/j.jacbts.2018.07.006. eCollection 2018 Oct.

10.

Hyperkalaemia in Heart Failure-Pathophysiology, Implications and Therapeutic Perspectives.

Llubani R, Vukadinović D, Werner C, Marx N, Zewinger S, Böhm M.

Curr Heart Fail Rep. 2018 Dec;15(6):390-397. doi: 10.1007/s11897-018-0413-9. Review.

PMID:
30421355
11.

Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.

Rosenstock J, Perkovic V, Johansen OE, Cooper ME, Kahn SE, Marx N, Alexander JH, Pencina M, Toto RD, Wanner C, Zinman B, Woerle HJ, Baanstra D, Pfarr E, Schnaidt S, Meinicke T, George JT, von Eynatten M, McGuire DK; CARMELINA Investigators.

JAMA. 2018 Nov 9. doi: 10.1001/jama.2018.18269. [Epub ahead of print]

PMID:
30418475
12.

[Pacemaker and ICD-Therapy - Relevant to the Non-Cardiologist].

Marx N.

Dtsch Med Wochenschr. 2018 Nov;143(22):1585. doi: 10.1055/a-0560-3240. Epub 2018 Oct 30. German. No abstract available.

PMID:
30376681
13.

Co-localization of plaque macrophages with calcification is associated with a more vulnerable plaque phenotype and a greater calcification burden in coronary target segments as determined by OCT.

Burgmaier M, Milzi A, Dettori R, Burgmaier K, Marx N, Reith S.

PLoS One. 2018 Oct 24;13(10):e0205984. doi: 10.1371/journal.pone.0205984. eCollection 2018.

14.

Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology.

Maack C, Lehrke M, Backs J, Heinzel FR, Hulot JS, Marx N, Paulus WJ, Rossignol P, Taegtmeyer H, Bauersachs J, Bayes-Genis A, Brutsaert D, Bugger H, Clarke K, Cosentino F, De Keulenaer G, Dei Cas A, González A, Huelsmann M, Iaccarino G, Lunde IG, Lyon AR, Pollesello P, Rena G, Riksen NP, Rosano G, Staels B, van Laake LW, Wanner C, Farmakis D, Filippatos G, Ruschitzka F, Seferovic P, de Boer RA, Heymans S.

Eur Heart J. 2018 Dec 21;39(48):4243-4254. doi: 10.1093/eurheartj/ehy596. No abstract available.

15.

SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseases.

Wanner C, Marx N.

Diabetologia. 2018 Oct;61(10):2134-2139. doi: 10.1007/s00125-018-4678-z. Epub 2018 Aug 22. Review.

PMID:
30132035
16.

Impact of multidrug-resistant bacteria on outcome in patients with prolonged weaning.

Bickenbach J, Schöneis D, Marx G, Marx N, Lemmen S, Dreher M.

BMC Pulm Med. 2018 Aug 20;18(1):141. doi: 10.1186/s12890-018-0708-3.

17.

Whole-Body Plethysmography and Blood Gas Analysis in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.

Dreher M, Daher A, Keszei A, Marx N, Müller T, Cornelissen C, Brandenburg V.

Respiration. 2019;97(1):24-33. doi: 10.1159/000491096. Epub 2018 Aug 15.

PMID:
30110686
18.

Glucagon-Like Peptide 1 and Its Cleavage Products Are Renoprotective in Murine Diabetic Nephropathy.

Moellmann J, Klinkhammer BM, Onstein J, Stöhr R, Jankowski V, Jankowski J, Lebherz C, Tacke F, Marx N, Boor P, Lehrke M.

Diabetes. 2018 Nov;67(11):2410-2419. doi: 10.2337/db17-1212. Epub 2018 Aug 13.

PMID:
30104246
19.

Cardiovascular protection in type 2 diabetes: Insights from recent outcome trials.

Bailey CJ, Marx N.

Diabetes Obes Metab. 2019 Jan;21(1):3-14. doi: 10.1111/dom.13492. Epub 2018 Sep 7. Review.

PMID:
30091169
20.

Reduced post-operative DPP4 activity associated with worse patient outcome after cardiac surgery.

Noels H, Theelen W, Sternkopf M, Jankowski V, Moellmann J, Kraemer S, Lehrke M, Marx N, Martin L, Marx G, Jankowski J, Goetzenich A, Stoppe C.

Sci Rep. 2018 Aug 7;8(1):11820. doi: 10.1038/s41598-018-30235-w.

21.

Myocardial infarction is sufficient to increase GLP-1 secretion, leading to improved left ventricular contractility and mitochondrial respiratory capacity.

Diebold S, Moellmann J, Kahles F, Haj-Yehia E, Liehn EA, Nickel A, Lebherz C, Maack C, Marx N, Lehrke M.

Diabetes Obes Metab. 2018 Dec;20(12):2911-2918. doi: 10.1111/dom.13472. Epub 2018 Aug 16.

PMID:
30033664
22.

Comprehensive pharmaceutical care to prevent drug-related readmissions of dependent-living elderly patients: a randomized controlled trial.

Lenssen R, Schmitz K, Griesel C, Heidenreich A, Schulz JB, Trautwein C, Marx N, Fitzner C, Jaehde U, Eisert A.

BMC Geriatr. 2018 Jun 4;18(1):135. doi: 10.1186/s12877-018-0814-3.

23.

The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE-/- mice by blocking monocyte/macrophage activation.

Kahles F, Liberman A, Halim C, Rau M, Möllmann J, Mertens RW, Rückbeil M, Diepolder I, Walla B, Diebold S, Burgmaier M, Lebherz C, Marx N, Lehrke M.

Mol Metab. 2018 Aug;14:150-157. doi: 10.1016/j.molmet.2018.05.014. Epub 2018 May 23.

24.

CRISPR-Based Targeted Epigenetic Editing Enables Gene Expression Modulation of the Silenced Beta-Galactoside Alpha-2,6-Sialyltransferase 1 in CHO Cells.

Marx N, Grünwald-Gruber C, Bydlinski N, Dhiman H, Ngoc Nguyen L, Klanert G, Borth N.

Biotechnol J. 2018 Oct;13(10):e1700217. doi: 10.1002/biot.201700217. Epub 2018 Jun 11.

PMID:
29802757
25.

High-Dose Ferric Carboxymaltose in Patients With HFrEF Induces Significant Hypophosphatemia.

Stöhr R, Sandstede L, Heine GH, Marx N, Brandenburg V.

J Am Coll Cardiol. 2018 May 15;71(19):2270-2271. doi: 10.1016/j.jacc.2018.03.448. No abstract available.

PMID:
29747838
26.

Mechanisms of cardiovascular complications in chronic kidney disease: research focus of the Transregional Research Consortium SFB TRR219 of the University Hospital Aachen (RWTH) and the Saarland University.

Marx N, Noels H, Jankowski J, Floege J, Fliser D, Böhm M.

Clin Res Cardiol. 2018 Aug;107(Suppl 2):120-126. doi: 10.1007/s00392-018-1260-0. Epub 2018 May 4. Review.

PMID:
29728829
27.

Predictors for target lesion microcalcifications in patients with stable coronary artery disease: an optical coherence tomography study.

Reith S, Milzi A, Dettori R, Marx N, Burgmaier M.

Clin Res Cardiol. 2018 Sep;107(9):763-771. doi: 10.1007/s00392-018-1243-1. Epub 2018 Apr 13.

PMID:
29654434
28.

The new SFB/TRR219 Research Centre.

Noels H, Boor P, Goettsch C, Hohl M, Jahnen-Dechent W, Jankowski V, Kindermann I, Kramann R, Lehrke M, Linz D, Maack C, Niemeyer B, Roma LP, Schuett K, Speer T, Wagenpfeil S, Werner C, Zewinger S, Böhm M, Marx N, Floege J, Fliser D, Jankowski J.

Eur Heart J. 2018 Mar 21;39(12):975-977. doi: 10.1093/eurheartj/ehy083. No abstract available.

PMID:
29579229
29.

Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk.

Rosenstock J, Perkovic V, Alexander JH, Cooper ME, Marx N, Pencina MJ, Toto RD, Wanner C, Zinman B, Baanstra D, Pfarr E, Mattheus M, Broedl UC, Woerle HJ, George JT, von Eynatten M, McGuire DK; CARMELINA® investigators.

Cardiovasc Diabetol. 2018 Mar 14;17(1):39. doi: 10.1186/s12933-018-0682-3.

30.

Adipose tissue ATGL modifies the cardiac lipidome in pressure-overload-induced left ventricular failure.

Salatzki J, Foryst-Ludwig A, Bentele K, Blumrich A, Smeir E, Ban Z, Brix S, Grune J, Beyhoff N, Klopfleisch R, Dunst S, Surma MA, Klose C, Rothe M, Heinzel FR, Krannich A, Kershaw EE, Beule D, Schulze PC, Marx N, Kintscher U.

PLoS Genet. 2018 Jan 10;14(1):e1007171. doi: 10.1371/journal.pgen.1007171. eCollection 2018 Jan.

31.

Opportunities and challenges of large-scale screening for atrial fibrillation.

Zink MD, Marx N, Crijns HJGM, Schotten U.

Herzschrittmacherther Elektrophysiol. 2018 Mar;29(1):57-61. doi: 10.1007/s00399-017-0550-y. Epub 2018 Jan 8. Review.

32.

Trimethylamine-N-oxide and Heart Failure With Reduced Versus Preserved Ejection Fraction.

Schuett K, Kleber ME, Scharnagl H, Lorkowski S, März W, Niessner A, Marx N, Meinitzer A.

J Am Coll Cardiol. 2017 Dec 26;70(25):3202-3204. doi: 10.1016/j.jacc.2017.10.064. No abstract available.

33.

Annexin A5 reduces early plaque formation in ApoE -/- mice.

Stöhr R, Schurgers L, van Gorp R, Jaminon A, Marx N, Reutelingsperger C.

PLoS One. 2017 Dec 21;12(12):e0190229. doi: 10.1371/journal.pone.0190229. eCollection 2017.

34.

In vivo quantification of amyloid burden in TTR-related cardiac amyloidosis.

Kollikowski AM, Kahles F, Kintsler S, Hamada S, Reith S, Knüchel R, Röcken C, Mottaghy FM, Marx N, Burgmaier M.

Intractable Rare Dis Res. 2017 Nov;6(4):291-294. doi: 10.5582/irdr.2017.01065.

35.

Type 2 diabetes mellitus is associated with a lower fibrous cap thickness but has no impact on calcification morphology: an intracoronary optical coherence tomography study.

Milzi A, Burgmaier M, Burgmaier K, Hellmich M, Marx N, Reith S.

Cardiovasc Diabetol. 2017 Dec 1;16(1):152. doi: 10.1186/s12933-017-0635-2.

36.

Sclerostin deficiency modifies the development of CKD-MBD in mice.

Kaesler N, Verhulst A, De Maré A, Deck A, Behets GJ, Hyusein A, Evenepoel P, Floege J, Marx N, Babler A, Kramer I, Kneissel M, Kramann R, Weis D, D'Haese PC, Brandenburg VM.

Bone. 2018 Feb;107:115-123. doi: 10.1016/j.bone.2017.11.015. Epub 2017 Nov 21.

PMID:
29175269
37.

[Abnormal blood count - how to deal with an altered platelet and leukocytes count].

Marx N.

Dtsch Med Wochenschr. 2017 Nov;142(23):1717. doi: 10.1055/s-0042-109211. Epub 2017 Nov 16. German. No abstract available.

PMID:
29145676
38.

[Non-ST-Segment Elevation Myocardial Infarction Caused by Spontaneous Coronary Thrombosis by Intimal Rupture].

Kahles F, Schuh A, Lehrke M, Burgmaier M, Marx N, Reith S.

Dtsch Med Wochenschr. 2017 Nov;142(22):1686-1689. doi: 10.1055/s-0043-118633. Epub 2017 Oct 27. German.

PMID:
29078214
39.

Unobtrusive Nocturnal Heartbeat Monitoring by a Ballistocardiographic Sensor in Patients with Sleep Disordered Breathing.

Zink MD, Brüser C, Stüben BO, Napp A, Stöhr R, Leonhardt S, Marx N, Mischke K, Schulz JB, Schiefer J.

Sci Rep. 2017 Oct 13;7(1):13175. doi: 10.1038/s41598-017-13138-0.

40.

Intensivmedizinische Aspekte der interventionellen Therapie von Herzklappenerkrankungen.

Reith S, Marx N.

Dtsch Med Wochenschr. 2017 Oct;142(20):1514-1518. doi: 10.1055/s-0043-100638. Epub 2017 Oct 10. German.

PMID:
29017208
41.

Multi-centre study of whole-heart dynamic 3D cardiac magnetic resonance perfusion imaging for the detection of coronary artery disease defined by fractional flow reserve: gender based analysis of diagnostic performance.

Hamada S, Gotschy A, Wissmann L, Paetsch I, Jahnke C, Plein S, Gebker R, Oebel S, Alkadhi H, Marx N, Lüscher TF, Kozerke S, Manka R.

Eur Heart J Cardiovasc Imaging. 2017 Oct 1;18(10):1099-1106. doi: 10.1093/ehjci/jex160.

PMID:
28984890
42.

Transcatheter aortic valve-in-valve implantation of a CoreValve in a JenaValve prosthesis: a case report.

Lotfi S, Becker M, Moza A, Autschbach R, Marx N, Schröder J.

J Med Case Rep. 2017 Sep 10;11(1):256. doi: 10.1186/s13256-017-1409-x.

43.

Effect of Empagliflozin on the Metabolic Signature of Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease.

Kappel BA, Lehrke M, Schütt K, Artati A, Adamski J, Lebherz C, Marx N.

Circulation. 2017 Sep 5;136(10):969-972. doi: 10.1161/CIRCULATIONAHA.117.029166. No abstract available.

PMID:
28874423
44.

The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors.

Butler J, Hamo CE, Filippatos G, Pocock SJ, Bernstein RA, Brueckmann M, Cheung AK, George JT, Green JB, Januzzi JL, Kaul S, Lam CSP, Lip GYH, Marx N, McCullough PA, Mehta CR, Ponikowski P, Rosenstock J, Sattar N, Salsali A, Scirica BM, Shah SJ, Tsutsui H, Verma S, Wanner C, Woerle HJ, Zannad F, Anker SD; EMPEROR Trials Program.

Eur J Heart Fail. 2017 Nov;19(11):1390-1400. doi: 10.1002/ejhf.933. Epub 2017 Aug 24. Review.

45.

Composite Primary End Points in Cardiovascular Outcomes Trials Involving Type 2 Diabetes Patients: Should Unstable Angina Be Included in the Primary End Point?

Marx N, McGuire DK, Perkovic V, Woerle HJ, Broedl UC, von Eynatten M, George JT, Rosenstock J.

Diabetes Care. 2017 Sep;40(9):1144-1151. doi: 10.2337/dc17-0068.

PMID:
28830955
46.

Leaving the Glucocentric View: Can SGLT2 Inhibitors Halt CVD in Patients With Type 2 Diabetes?

Marx N.

J Am Coll Cardiol. 2017 Aug 8;70(6):713-714. doi: 10.1016/j.jacc.2017.06.037. No abstract available.

47.

Electrical impedance tomography for predicting failure of spontaneous breathing trials in patients with prolonged weaning.

Bickenbach J, Czaplik M, Polier M, Marx G, Marx N, Dreher M.

Crit Care. 2017 Jul 12;21(1):177. doi: 10.1186/s13054-017-1758-2.

48.

Diabetes Mellitus and Heart Failure.

Lehrke M, Marx N.

Am J Cardiol. 2017 Jul 1;120(1S):S37-S47. doi: 10.1016/j.amjcard.2017.05.014. Epub 2017 May 30. Review.

49.

Circulating annexin A5 levels are associated with carotid intima-media thickness but not coronary plaque composition.

Burgmaier M, Reith S, Schurgers L, Kahles F, Marx N, Reutelingsperger C.

Diab Vasc Dis Res. 2017 Sep;14(5):415-422. doi: 10.1177/1479164117710392. Epub 2017 Jun 7.

PMID:
28592134
50.

Erratum to: Intra-procedural determination of viability by myocardial deformation imaging: a randomized prospective study in the cardiac catheter laboratory.

Schuh A, Karayusuf V, Altiok E, Hamada S, Schröder J, Keszei A, Kelm M, de la Fuente M, Frick M, Radermacher K, Marx N, Becker M.

Clin Res Cardiol. 2017 Oct;106(10):850. doi: 10.1007/s00392-017-1125-y. No abstract available.

PMID:
28577255

Supplemental Content

Support Center